Literature DB >> 26408082

Placental pathology is associated with severity of neonatal encephalopathy and adverse developmental outcomes following hypothermia.

Imran N Mir1, Sarah F Johnson-Welch2, David B Nelson3, Larry S Brown4, Charles R Rosenfeld1, Lina F Chalak5.   

Abstract

OBJECTIVE: Although neonatal encephalopathy (NE) due to perinatal asphyxia accounts for a notable proportion of brain injury, the causal pathway remains largely unexplained. We sought to determine the association of placental pathology with: (1) severity of NE in the first 6 hours postnatal, and (2) abnormal neurodevelopmental outcomes (NDO) in neonates requiring hypothermia therapy. STUDY
DESIGN: This is a retrospective cohort study of neonates ≥36 weeks' gestation born at Parkland Hospital, Dallas, TX, from January 2006 through November 2011 with NE. Placental histology was reviewed and validated by a pediatric pathologist blinded to outcomes. Abnormal NDO was defined as death or Bayley-III score of <85 at 18-24 months of age.
RESULTS: Of 86,274 neonates ≥36 weeks' gestation, 120 had evidence of a combination of perinatal acidosis and NE. In all, 47 had mild NE and received no treatment, while 73 had moderate (n = 70) or severe (n = 3) NE and received systemic hypothermia. Nine neonates died and all survivors receiving hypothermia had a Bayley-III assessment at 22 ± 7 (SD) months of age. Chorioamnionitis with or without fetal response and patchy/diffuse chronic villitis were found to be independently associated with severity of NE (P < .001). Univariate logistic regression revealed an association with a diagnosis of major placental pathology (odds ratio, 3.5; 95% confidence interval, 1.1-11.4) and abnormal outcomes following cooling. Specifically, diffuse chronic villitis (odds ratio, 9.29; 95% confidence interval, 1.11-77.73) was the only individual predictor of abnormal NDO following hypothermia therapy.
CONCLUSION: Placental inflammatory villitis appears to be a harbinger of abnormal outcomes in neonates with NE, spanning to the 18-24 month NDO.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  hypothermia; hypoxic ischemic encephalopathy; neonatal encephalopathy; neurodevelopmental outcome

Mesh:

Year:  2015        PMID: 26408082     DOI: 10.1016/j.ajog.2015.09.072

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Placental pathology and outcome after perinatal asphyxia and therapeutic hypothermia.

Authors:  C M C Frank; P G J Nikkels; J C Harteman; I C van Haastert; M J N L Benders; C Koopman-Esseboom; L S de Vries; F Groenendaal
Journal:  J Perinatol       Date:  2016-08-18       Impact factor: 2.521

2.  The alarmin S100A12 causes sterile inflammation of the human chorioamniotic membranes as well as preterm birth and neonatal mortality in mice†.

Authors:  Kenichiro Motomura; Roberto Romero; Olesya Plazyo; Valeria Garcia-Flores; Meyer Gershater; Jose Galaz; Derek Miller; Nardhy Gomez-Lopez
Journal:  Biol Reprod       Date:  2021-12-20       Impact factor: 4.161

Review 3.  Pathophysiology of Perinatal Asphyxia in Humans and Animal Models.

Authors:  Daniel Mota-Rojas; Dina Villanueva-García; Alfonso Solimano; Ramon Muns; Daniel Ibarra-Ríos; Andrea Mota-Reyes
Journal:  Biomedicines       Date:  2022-02-01

Review 4.  Inflammatory Biomarkers of Birth Asphyxia.

Authors:  Lina F Chalak
Journal:  Clin Perinatol       Date:  2016-09       Impact factor: 3.430

5.  Maternal chorioamnionitis and neurodevelopmental outcomes in preterm and very preterm neonates: A meta-analysis.

Authors:  Dongqiong Xiao; Tingting Zhu; Yi Qu; Xiaoyun Gou; Qun Huang; Xihong Li; Dezhi Mu
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

6.  Placental assessment provides insight into mechanisms and timing of neonatal hypoxic-ischemic encephalopathy.

Authors:  Joseph J Volpe
Journal:  J Neonatal Perinatal Med       Date:  2019

7.  Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation.

Authors:  Jessica L Wisnowski; Stefan Bluml; Ashok Panigrahy; Amit M Mathur; Jeffrey Berman; Ping-Sun Keven Chen; James Dix; Trevor Flynn; Stanley Fricke; Seth D Friedman; Hayden W Head; Chang Y Ho; Beth Kline-Fath; Michael Oveson; Richard Patterson; Sumit Pruthi; Nancy Rollins; Yanerys M Ramos; John Rampton; Jerome Rusin; Dennis W Shaw; Mark Smith; Jean Tkach; Shreyas Vasanawala; Arastoo Vossough; Matthew T Whitehead; Duan Xu; Kristen Yeom; Bryan Comstock; Patrick J Heagerty; Sandra E Juul; Yvonne W Wu; Robert C McKinstry
Journal:  BMJ Open       Date:  2021-04-22       Impact factor: 2.692

8.  Neurological Outcome Following Newborn Encephalopathy With and Without Perinatal Infection: A Systematic Review.

Authors:  Mads Andersen; Mette Vestergård Pedersen; Ted Carl Kejlberg Andelius; Kasper Jacobsen Kyng; Tine Brink Henriksen
Journal:  Front Pediatr       Date:  2021-12-20       Impact factor: 3.418

Review 9.  What is known about neuroplacentology in fetal growth restriction and in preterm infants: A narrative review of literature.

Authors:  Barbara Gardella; Mattia Dominoni; Annachiara Licia Scatigno; Stefania Cesari; Giacomo Fiandrino; Simona Orcesi; Arsenio Spinillo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

Review 10.  Neonatal Encephalopathy: Need for Recognition of Multiple Etiologies for Optimal Management.

Authors:  Saima Aslam; Tammy Strickland; Eleanor J Molloy
Journal:  Front Pediatr       Date:  2019-04-16       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.